Risk factors and Alzheimer's disease: a comparative study of two communities

References

• Jorm A F, Korten A E, Henderson A S. The prevalance of dementia: a quantative integration of the literature. Acta Psychiatrica Scandinavica 1987; 76: 465–479
   PubMed Web of Science ®Google Scholar
• Evans D A, Funkenstein H H, Albert M S, et al. Prevalance of Alzheimer's disease in a community population of older persons higher than previously reported. Journal of the Australian Medical Association 1989; 262: 2551–2556
   PubMed Web of Science ®Google Scholar
• Canadian Study of Health and Aging Working Group. Canadian study of health and aging: study methods and prevalance of dementia. Canadian Medical Association Journal 1994; 150: 899–913
   PubMed Web of Science ®Google Scholar
• Paykel E S, Brayne C, Huppert F A, et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Archives of General Psychiatry 1994; 51: 325–332
   PubMedGoogle Scholar
• Class C A, Unverzagt F W, Gao S J, et al. Psychiatric disorders in African-American nursing home residents. American Journal of Psychiatry 1996; 153: 677–681
   PubMed Web of Science ®Google Scholar
• Osuntokun B O, Hendrie H C, Ogunniyi A O, et al. Cross cultural studies in Alzheimer's disease. Ethnicity Disease 1992; 2: 352–357
   PubMedGoogle Scholar
• Jorm A F. Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias. European Archives of Psychiatry and Clinical Neumscience 1991; 240: 218–222
   PubMed Web of Science ®Google Scholar
• Hendrie H C, Osuntokun B O, Hall K S, et al. The prevelance of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. American Journal of Psychiatry 1995; 152: 1485–1492
   PubMed Web of Science ®Google Scholar
• Schellenberg G D. Genetic dissection of Alzheimer's disease, a heterogenous disorder. Proceedings of the National Academy of the United States of America 1995; 92: 8552–8559
   PubMed Web of Science ®Google Scholar
• Van Broeckhoven C. Presenilins and Alzheimer's disease. Nature Genetics 1995; 11: 230–232
   PubMed Web of Science ®Google Scholar
• Blacker D, Haines J L, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's Disease: the NIMH genetics initiative. Neurology 1997; 48: 139–147
   PubMed Web of Science ®Google Scholar
• Anonymous. Statement of the use of apolipoprotein E testing for Alheimer's Disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer's Disease. Journal of the American Medical Association 1995; 274: 1627–1629
   Google Scholar
• Henderson A S. The risk factors for Alzheimer's disease: a review and a hypothesis. Acta Psychiatrica Scandinavica 1988; 78: 257–275
   PubMed Web of Science ®Google Scholar
• Kukull W A, Larson E B, Bowden J D, et al. Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. American Journal of Epidemiology 1995; 141: 1059–1079
   PubMed Web of Science ®Google Scholar
• Anonymous. The Canadian Study of Health and Aging; risk factors for Alzheimer's disease in Canada. Neurology 1994; 44: 2073–2080
   PubMedGoogle Scholar
• Graves A B, Van Duijn C M, Chandra V, et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. International Journal of Epidemiology 1991; 20: S58–S61
   PubMedGoogle Scholar
• Hebert L E, Scherr P A, Beckett L A. Relation of smoking and alcohol consumption to incident Alzheimer's disease. American Journal of Epidemiology 1992; 135: 347–355
   PubMed Web of Science ®Google Scholar
• Stephenson J. More evidence links NSAID, estrogen use with reduced Alzheimer's risk. Journal of the American Medical Association 1996; 275: 1389–1390
   Google Scholar
• Tang M X, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429–432
   PubMed Web of Science ®Google Scholar
• National Advisory Council on Aging. National Advisory Council on Aging. 1995, Report to Congress on the scientific opportunities for developing treatments for Alzheimer's disease.
   Google Scholar
• Hendrie H C, Hall K S, Hui S., et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Annals of Neurology 1995; 37: 118–120
   PubMedGoogle Scholar
• Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Annals of Neurology 1995; 37: 254–259
   PubMedGoogle Scholar
• Osuntokun B O, Sahota A, Ogunniyi A O. Lack of an association between Apolipoprotein E G4 and Alzheimer's disease in elderly Nigerians. Annals of Neurology 1995; 38: 463–465
   PubMed Web of Science ®Google Scholar
• Hall K S, Ogunniyi A O, Hendrie H C, et al. A cross-cultural community based study of dementias; methods and performance of the survey instrument Indianapolis, U.S.A. and Ibadan, Nigeria. International Journal of Methods in Psychiatry Research 1996; 6: 129–142
   Web of Science ®Google Scholar
• Morris J C, Heyman A, Mom R C, et al. The Consortium to Establish a Registry For Alzheimer's Disease (CERAD). Part I. Clinical and neuropyschological assessment of Alzheimer's disease. Neurology 1989; 39: 149–155
   PubMedGoogle Scholar
• Gureje O, Unverzagt F W, Osuntokun B O, et al. The CERAD neuropsychological test battery: norms from a Yoruba-speaking Nigerian sample. West African Journal of Medicine 1995; 14: 29–33
   PubMedGoogle Scholar
• Unverzagt F W, Hall K S, Torke A M, et al. Effects of age, education, and gender on CERAD Neuropsychological Test performance in an African American sample. The Clinical Neuropsychologist 1996; 10: 180–190
   Web of Science ®Google Scholar
• Hughes C P, Berg L, Danziger W L, et al. A new clinical scale for the staging of dementia. British Journal of Psychiatry 1982; 140: 566–572
   PubMed Web of Science ®Google Scholar
• Mc Khann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944
   PubMed Web of Science ®Google Scholar
• Sudaan. Software for the statistical analysis of correlated data, users manual. Research Triangle Institute, Research Triangle Park, NC 1996
   Google Scholar
• Peduzzi P, Concato J, Kemper E, Holford T R, Feinstein A R. A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology 1996; 49: 1373–1379
   PubMed Web of Science ®Google Scholar
• Duara R, Barker W W, Lopez-Alberola R, et al. Alzheimer's disease: interaction of apolipoprotein E genotypes, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 1996; 46: 1575–1579
   PubMed Web of Science ®Google Scholar
• Barclay L L, Zemcov A, Blass J P, Sansone J. Survival in Alzheimer's disease and vascular dementias. Neurology 1985; 35: 834–840
   PubMed Web of Science ®Google Scholar
• Bachman D L, Wolf P A, Linn R T, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993; 43: 515–519
   PubMed Web of Science ®Google Scholar